Magnetic resonance imaging methodology

IntroductionMagnetic resonance (MR) methods are non-invasive techniques to provide detailed, multi-parametric information on human anatomy, function and metabolism. Sensitivity, specificity, spatial and temporal resolution may, however, vary depending on hardware (e.g., field strength, gradient strength and speed) and software (optimised measurement protocols and parameters for the various techniques). Furthermore, multi-modality imaging may enhance specificity to better characterise complex disease patterns.ObjectivePositron emission tomography (PET) is an interesting, largely complementary modality, which might be combined with MR. Despite obvious advantages, combining these rather different physical methods may also pose challenging problems. At this early stage, it seems that PET quality may be preserved in the magnetic field and, if an adequate detector material is used for the PET, MR sensitivity should not be significantly degraded. Again, this may vary for the different MR techniques, whereby functional and metabolic MR is more susceptible than standard anatomical imaging.DiscussionHere we provide a short introduction to MR basics and MR techniques, also discussing advantages, artefacts and problems when MR hardware and PET detectors are combined. In addition to references for more detailed descriptions of MR fundamentals and applications, we provide an early outlook on this novel and exciting multi-modality approach to PET/MR.

[1]  Yu-Chung N. Cheng,et al.  Magnetic Resonance Imaging: Physical Principles and Sequence Design , 1999 .

[2]  Timothy P L Roberts,et al.  Neuro MR: Principles , 2007, Journal of magnetic resonance imaging : JMRI.

[3]  Bradford A. Moffat,et al.  Diffusion MRI: A New Strategy for Assessment of Cancer Therapeutic Efficacy , 2002, Molecular imaging.

[4]  D. Le Bihan,et al.  Artifacts and pitfalls in diffusion MRI , 2006, Journal of magnetic resonance imaging : JMRI.

[5]  Ewald Moser,et al.  High‐resolution 3D proton spectroscopic imaging of the human brain at 3 T: SNR issues and application for anatomy‐matched voxel sizes , 2003, Magnetic resonance in medicine.

[6]  Gerard J. den Heeten,et al.  Functional magnetic resonance imaging for neurosurgical planning in neurooncology , 2004, European Radiology.

[7]  K P Pruessmann,et al.  Sensitivity‐encoded spectroscopic imaging , 2001, Magnetic resonance in medicine.

[8]  Deming Wang,et al.  Geometric distortion in clinical MRI systems Part I: evaluation using a 3D phantom. , 2004, Magnetic resonance imaging.

[9]  Matt A Bernstein,et al.  Imaging artifacts at 3.0T , 2006, Journal of magnetic resonance imaging : JMRI.

[10]  A. Sorensen,et al.  Magnetic resonance as a cancer imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. Debatin,et al.  Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 minutes: a feasibility study. , 2002, AJR. American journal of roentgenology.

[12]  D. Tank,et al.  Brain magnetic resonance imaging with contrast dependent on blood oxygenation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Debatin,et al.  Whole-body MR imaging: evaluation of patients for metastases. , 2004, Radiology.

[14]  C. Mountford,et al.  Proton spectroscopy provides accurate pathology on biopsy and in vivo , 2006, Journal of magnetic resonance imaging : JMRI.

[15]  Christopher Nimsky,et al.  Metabolic Imaging of Cerebral Gliomas: Spatial Correlation of Changes in O-(2-18F-Fluoroethyl)-l-Tyrosine PET and Proton Magnetic Resonance Spectroscopic Imaging , 2008, Journal of Nuclear Medicine.

[16]  Ciprian Catana,et al.  Simultaneous PET-MRI: a new approach for functional and morphological imaging , 2008, Nature Medicine.

[17]  S. Schoenberg,et al.  Whole-body MRI and PET-CT in the management of cancer patients , 2006, European Radiology.

[18]  Armin Kolb,et al.  Positron emission tomography/magnetic resonance imaging: the next generation of multimodality imaging? , 2008, Seminars in nuclear medicine.

[19]  C Windischberger,et al.  Improvement of presurgical patient evaluation by generation of functional magnetic resonance risk maps , 2000, Neuroscience Letters.

[20]  D. Le Bihan,et al.  Diffusion tensor imaging: Concepts and applications , 2001, Journal of magnetic resonance imaging : JMRI.

[21]  J. Debatin,et al.  Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. , 2003, JAMA.

[22]  D. Norris Principles of magnetic resonance assessment of brain function , 2006, Journal of magnetic resonance imaging : JMRI.

[23]  N R Jagannathan,et al.  Biochemical characterization of metastatic lymph nodes of breast cancer patients by in vitro 1H magnetic resonance spectroscopy: a pilot study. , 2004, Magnetic resonance imaging.

[24]  J D Bourland,et al.  Review of Patient Safety in Time‐Varying Gradient Fields , 2000, Journal of magnetic resonance imaging : JMRI.

[25]  Deming Wang,et al.  Geometric distortion in clinical MRI systems Part II: correction using a 3D phantom. , 2004, Magnetic resonance imaging.

[26]  J. Detre,et al.  Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system. , 1999, European journal of radiology.

[27]  J Kurhanewicz,et al.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. , 2000, Neoplasia.

[28]  A Gregory Sorensen,et al.  Diffusion tensor magnetic resonance imaging of brain tumors. , 2005, Neurosurgery clinics of North America.

[29]  Siegfried Kasper,et al.  Multimodal imaging of human early visual cortex by combining functional and molecular measurements with fMRI and PET , 2008, NeuroImage.

[30]  J. Debatin,et al.  Rapid magnetic resonance angiography for detection of atherosclerosis , 2001, The Lancet.

[31]  D. Larkman,et al.  Parallel magnetic resonance imaging , 2007, Physics in medicine and biology.

[32]  Wolfgang Schima,et al.  Artifacts in body MR imaging: their appearance and how to eliminate them , 2007, European Radiology.

[33]  N. Hylton Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  David M. Doddrell,et al.  Geometric distortion in clinical MRI systems Part II: correction using a 3D phantom. , 2004, Magnetic resonance imaging.